Serological Approaches
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F17%3A00065993" target="_blank" >RIV/65269705:_____/17:00065993 - isvavai.cz</a>
Výsledek na webu
<a href="https://link.springer.com/protocol/10.1007%2F978-1-4939-6515-1_11#citeas" target="_blank" >https://link.springer.com/protocol/10.1007%2F978-1-4939-6515-1_11#citeas</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-1-4939-6515-1_11" target="_blank" >10.1007/978-1-4939-6515-1_11</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Serological Approaches
Popis výsledku v původním jazyce
The diagnosis of invasive fungal diseases (IFD) based on clinical, radiological, and conventional microbiological findings is not reliable and is often delayed. Non-culture-based methods with higher sensitivity and specificity may reduce diagnostic time and result in decreased IFD morbidity and mortality. These methods are now increasingly used to manage patients at risk of IFD. Among available biomarkers, fungal antigens have been investigated as an aid to early diagnosis and are predominantly used as screening tests to prompt antifungal treatment mainly in patients with hematological malignancies. The revised version of the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) consensus definitions includes some of these biological markers (galactomannan, 1,3-beta-d-glucan, cryptococcus antigen).
Název v anglickém jazyce
Serological Approaches
Popis výsledku anglicky
The diagnosis of invasive fungal diseases (IFD) based on clinical, radiological, and conventional microbiological findings is not reliable and is often delayed. Non-culture-based methods with higher sensitivity and specificity may reduce diagnostic time and result in decreased IFD morbidity and mortality. These methods are now increasingly used to manage patients at risk of IFD. Among available biomarkers, fungal antigens have been investigated as an aid to early diagnosis and are predominantly used as screening tests to prompt antifungal treatment mainly in patients with hematological malignancies. The revised version of the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) consensus definitions includes some of these biological markers (galactomannan, 1,3-beta-d-glucan, cryptococcus antigen).
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
—
OECD FORD obor
10608 - Biochemistry and molecular biology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Human Fungal Pathogen Identification : Methods and Protocols
ISBN
978-1-4939-6515-1
Počet stran výsledku
13
Strana od-do
1-13
Počet stran knihy
453
Název nakladatele
Humana Press
Místo vydání
New York
Kód UT WoS kapitoly
—